EMMA CABUSAO: Open Payments
NPI 1417911744 · WHEATON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,010 in 45 payments from 16 companies in 2025. Trend: 2023 $659 · 2024 $903 · 2025 $1,010
Food & beverage: $1,010
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $190 |
| Axsome Therapeutics, Inc. | 5 | $109 |
| Vanda Pharmaceuticals Inc. | 3 | $81 |
| Neurocrine BioSciences, Inc. | 3 | $75 |
| ABBVIE INC. | 4 | $69 |
| E.R. Squibb & Sons, L.L.C. | 3 | $69 |
| Corium, LLC | 3 | $61 |
| Teva Pharmaceuticals USA, Inc. | 3 | $60 |
| Collegium Pharmaceutical, Inc. | 2 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
Products named: REXULTI, FANAPT, Sunosi, INGREZZA, VRAYLAR, COBENFY, Azstarys, ABILIFY ASIMTUFII.
Industry payments across IL — which companies pay providers there.
